by Lance Smith | Jun 4, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Large trials that go unreported threaten the credibility of available, published evidence and are detrimental to the scientific process, according to a brief research report and an editorial published in Annals of Internal Medicine. Researchers identified the 500...by Lance Smith | Jun 4, 2019 | Study Scavenger Clinical Trial Recruitment Platform
French agency (ANSM) first to approve clinical trial with ABX464 in moderate to severe rheumatoid arthritis Trial to be conducted in 60 patients in five countries, with “first patient in” scheduled for early Q3 2019 Rheumatoid arthritis is a severe, debilitating...by Lance Smith | Jun 4, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Chinese authorities have greenlighted the clinical trial for the world’s first tetravalent vaccine against norovirus, the most common cause for viral gastroenteritis. The vaccine received the clinical research permit from the National Medical Products...by Lance Smith | Jun 4, 2019 | Study Scavenger Clinical Trial Recruitment Platform
ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today reported completion...by Lance Smith | Jun 3, 2019 | Study Scavenger Clinical Trial Recruitment Platform
– Georgetown University Medical Center announces the launch of the only known therapeutic (disease modifying) clinical trial for Lewy body dementia, a neurological disorder that affects a million people in the United States for which there are no approved medications...by Lance Smith | Jun 3, 2019 | Study Scavenger Clinical Trial Recruitment Platform
National Cancer Institute (NCI) Study Designed to Investigate Zotiraciclib in Combination with Temozolomide (TMZ) Presented During Poster Session at ASCO 2019 Maximum Tolerated Dose of Zotiraciclib (250mg) Elicits Tumor Reduction, Suggesting Activity in Glioblastoma...